Zobrazeno 1 - 10
of 886
pro vyhledávání: '"Kuliczkowski K."'
Autor:
Usnarska-Zubkiewicz, L., Dębski, J., Butrym, A., Legieć, W., Hus, M., Dmoszyńska, A., Stella-Hołowiecka, B., Zaucha, J.M., Januszczyk, J., Rymko, M., Torosian, T., Charliński, G., Lech-Marańda, E., Malenda, A., Jurczyszyn, A., Urbańska-Ryś, H., Druzd-Sitek, A., Błońska, D., Urbanowicz, A., Hołojda, J., Pogrzeba, J., Rzepecki, P., Hałka, J., Subocz, E., Becht, R., Zdziarska, B., Dytfeld, D., Nowicki, A., Bołkun, Ł., Kłoczko, J., Knopińska-Posłuszny, W., Zubkiewicz-Kucharska, A., Kuliczkowski, K.
Publikováno v:
In Leukemia Research January 2016 40:90-99
Multiple myeloma (MM) remains an incurable disease, with little information available on its management in real-world clinical practice. The results of the present prospective, noninterventional observational study revealed great diversity in the tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::121f2e22d1623bbbe181c3f9a1e47032
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3085843
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3085843
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sobas, M. A., Wróbel, T., Zduniak, K., Podolak-Dawidziak, M., Rybka, J., Biedroń, M., Sawicki, M., Dybko, J., Kuliczkowski, K.
Publikováno v:
Case Reports in Hematology.
We present the case where immune thrombocytopenia (ITP) and essential thrombocythemia (ET) sequentially appeared in the space of twenty-one years of follow-up. Impaired platelet production is present in both diseases, but clinical presentation and tr
In this double-blind, Phase 2 study, 220 patients with relapsed/refractory multiple myeloma were randomly assigned 1:1:1 to receive placebo (N�=�72), tabalumab 100�mg (N�=�74), or tabalumab 300�mg (N�=�74), each in combination with de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::67d41bc52fa63df5d722e8756f2c538b
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3108890
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3108890
Autor:
Dmoszynska, A.1, Kuliczkowski, K.2, Hellmann, A.3, Trelinski, J.4, Kloczko, J.5, Baglin, T.6, Hay, C.7, O'Shaughnessy, D.8, Zawilska, K.9, Makris, M.10, Shaikh-Zaidi, R.11, Gascoigne, E.11, Dash, C.11 clive.dash@bpl.co.uk
Publikováno v:
Haemophilia. May2011, Vol. 17 Issue 3, p456-462. 7p. 1 Diagram, 11 Charts.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
The purpose of this study is to assess the safety and efficacy of the combination of ofatumumab and bendamustine in patients with previously untreated or relapsed chronic lymphocytic leukemia. Patients received IV ofatumumab (cycle 1: 300 mg day 1 an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::695b9083105c239fe381b314aad65b75
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3124179
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3124179
Autor:
Urbaniak-Kujda, D., Kapelko-Słowik, K., Wołowiec, D., Dybko, J., Hałoń, A., Bożena Jaźwiec, Maj, J., Jankowska-Konsur, A., Kuliczkowski, K.
Publikováno v:
Postępy Higieny i Medycyny Doświadczalnej, Vol 63, Iss 835515, Pp 355-359 (2009)
Europe PubMed Central
Scopus-Elsevier
Europe PubMed Central
Scopus-Elsevier
Introduction: T cells with the CD8 CD28– phenotype are CD8 lymphocytes with regulatory function. Their increased numbers were observed in infections, autoimmune and neoplastic diseases, and in elderly healthy individuals. CD8 CD28– lymphocyte lev
Autor:
Afdhal NH, Giannini EG, Tayyab G, Mohsin A, Lee JW, Andriulli A, Jeffers L, McHutchison J, Chen PJ, Han KH, Campbell F, Hyde D, Brainsky A, Theodore D, ELEVATE Study Group […, Akram J, Bessonova E, Bilodeau M, Bloomer J, Botta Fridlund D, Bzowej N, Calmus Y, Carbonell N, Caro Patón A, Cholewinska G, Chuang WL, Colombato L, Colombo M, Craxi A, Di Leo A, Diago M, Dumortier J, Elkasahab M, Everson G, Fallon M, Fedeli G, Finazzi R, Fontanella A, Francavilla A, Gadano A, Gambarin Gelwan M, Gordon F, Graus Morales J, Grieco A, Gugenheim J, Homenda W, Iaquinto G, Kang H, Khan Z, Kuliczkowski K, Kwo P, Lee JH, Lee W, Lee YS, Mazur W, Moreno C, Morozov V, Muñoz A, Navasa Anadón M, Nijhawan S, Pinzello G, Poordad F, Prieto Castillo M, Rafalsky V, Rapaccini G, Regenstein F, Rewak W, Riley T, Ripoll Noiseux C, Rizzetto M, Rodrigo Lopez J, Russo M, Samuel D, Sánchez Antolín G, Satyanaryana R, Savarino V, Shiffman M, Sigal S, Solá Lamoglia R, Sterling R, Tanno H, Te H, Terg R, Thuluvath P, Trepo C, Vargas H, Xiol Quingles X, Zaman A, Fontana R, Kim K, Abrams C, Gish R, Cardenas A, ANDREONE, PIETRO, MAZZELLA, GIUSEPPE
Eltrombopag is an oral thrombopoietin-receptor agonist. This study evaluated the efficacy of eltrombopag for increasing platelet counts and reducing the need for platelet transfusions in patients with thrombocytopenia and chronic liver disease who ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94c4867da64475128d50da54cdaee7f6
http://hdl.handle.net/10807/33915
http://hdl.handle.net/10807/33915